Literature DB >> 22226270

Analysis of the NovoTwist pen needle in comparison with conventional screw-thread needles.

Tandy Aye1.   

Abstract

Administration of insulin via a pen device may be advantageous over a vial and syringe system. Hofman and colleagues introduce a new insulin pen needle, the NovoTwist, to simplify injections to a small group of children and adolescents. Their overall preferences and evaluation of the handling of the needle are reported in the study. This new needle has the potential to ease administration of insulin via a pen device that may increase both the use of a pen device and adherence to insulin therapy.
© 2011 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22226270      PMCID: PMC3262719          DOI: 10.1177/193229681100500624

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  5 in total

Review 1.  Considerations for diabetes: treatment with insulin pen devices.

Authors:  Robert M Cuddihy; Sarah K Borgman
Journal:  Am J Ther       Date:  2013 Nov-Dec       Impact factor: 2.688

2.  Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes.

Authors:  A N Lteif; W F Schwenk
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

3.  Needle with a novel attachment versus conventional screw-thread needles: a preference and ease-of-use test among children and adolescents with diabetes.

Authors:  Paul Hofman; Søren Kruse Lilleøre; Gitte Ter-Borch
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

Review 4.  Reusable and disposable insulin pens for the treatment of diabetes: understanding the global differences in user preference and an evaluation of inpatient insulin pen use.

Authors:  Riccardo Perfetti
Journal:  Diabetes Technol Ther       Date:  2010-06       Impact factor: 6.118

5.  Insulin devices: addressing barriers to insulin therapy with the ideal pen.

Authors:  Geralyn Spollett
Journal:  Diabetes Educ       Date:  2008 Nov-Dec       Impact factor: 2.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.